Evidence map›Paper›PMID 21141922›Full record

ArticleAnalytical chemistry2011

Hybrid activation methods for elucidating nucleic acid modifications.

Suncerae I Smith, Jennifer S Brodbelt

Abstract read
In one paragraph

Article in Analytical chemistry, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
2.3field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 51 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Phosphorothioate RNA Analysis by NETD Tandem Mass Spectrometry.Molecular & cellular proteomics : MCP · 2024
    Article
  6. Article
  7. Article
  8. Identification of URNA (New York, N.Y.) · 2023
    Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Comparison of MS/MS methods for characterization of DNA/cisplatin adducts.Journal of the American Society for Mass Spectrometry · 2013
    Article
  20. Shedding light on the frontier of photodissociation.Journal of the American Society for Mass Spectrometry · 2011
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Suncerae I SmithDepartment of Chemistry and Biochemistry, University of Texas at Austin, Austin, Texas 78712, United States.
Jennifer S Brodbelt
The University of Texas at Austin · US

Funding

Design and Characterization of DNA Interactive AgentsR01GM065956 · NIGMS · UNIVERSITY OF TEXAS AUSTIN · PI BRODBELT, JENNIFER S. · 2003 to 2011
$2.1M
NIGMS NIH HHS R01 GM065956NIGMS NIH HHS R01 GM65956
6 · The paper itself

Abstract

Hybrid tandem mass spectrometry (MS/MS) techniques combining electron transfer (ET) and collision activated dissociation (CAD), infrared multiphoton dissociation (IRMPD), or ultraviolet photodissociation (UVPD) were implemented and evaluated for the characterization of a series of oligonucleotides and oligoribonucleotides, including both native single strands and single strands containing platinated, phosphorothioated, and 2'-O-methylated modification sites. ET-IRMPD and ET-UVPD of oligodeoxynucleotides and oligoribonucleotides resulted in rich fragmentation with respect to production of w, a, z, and d ions for DNA, and c, y, w, a-B, d, and z ions for RNA, with many product ions retaining the modification and thus allowing site specific identification. ET-IRMPD caused more extensive secondary dissociation of the ions, in addition to a broader distribution of detectable sequence ions attributed to using a lower mass cutoff. ET-UVPD promoted higher energy fragmentation pathways and created the most diverse MS/MS spectra. The numerous products generated by the hybrid MS/MS techniques resulted in specific and extensive backbone cleavages which allowed the modification sites of multiply modified oligonucleotides to be elucidated.

Indexed as

Base SequenceCisplatinDNA, Single-StrandedElectron TransportNucleic AcidsOligonucleotides, AntisenseOligoribonucleotidesPhosphatesPhotochemical ProcessesTandem Mass SpectrometryCisplatinDNA, Single-StrandedNucleic AcidsOligonucleotides, AntisenseOligoribonucleotidesPhosphatesphosphorodithioic acid

Identifiers

PMID21141922
PMCPMC3012149
OpenAlexW1990550644

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.